IVD leading enterprise with the most complete product line in China

•Ailex was founded in August 2000, focusing on the R&D, production and service of in vitro diagnostic reagents and instruments. Its products cover the detection fields of biochemistry, immunity, saccharification, allergens, microorganisms and automated assembly line systems. It has two production bases and three R&D technology centers in Shanghai, Zhejiang Jiashan and Japan New Yokohama,Provide comprehensive product solutions and overall services for medical laboratories. 

•The company has established a nationally recognized enterprise technology center, Capital University Tokyo Joint Laboratory, Jiaxing Ailex Medical Engineering Technology Municipal High tech Research and Development Center, Jiaxing Academician and Expert Workstation, and has undertaken major projects in strategic emerging industries in Shanghai. 

•The company attaches great importance to product R&D and technological innovation, with R&D investment accounting for~10% of revenue in recent years;Pay attention to team building, technical R&D personnel account for more than 20% of the total number of the company;Compared with the international advanced enterprises and strict R&D process management, it has become one of the enterprises with more registration numbers and more comprehensive product lines in the industry. 

•At the end of 2018, the company's total assets were 605 million yuan, its net assets were 406 million yuan, and its annual operating revenue was 358 million yuan.  

•There are 120 open patents (86 invention patents), 72 authorized patents (25 invention patents), 149 CFDA certificates (190 calibration quality control).